|Articles|October 20, 2009
Daily Dose
Your daily dose of clinical tips and quips: Trilostane.
Advertisement
Untitled Document
“More than 85% of dogs have shown both clinical and biochemical improvement (decreased alkaline phosphatase activity and cholesterol concentration) after a month of trilostane therapy, with substantial improvements in post-ACTH stimulation cortisol concentrations.”
Advertisement
-Trilostane: A therapeutic consideration for canine hypoadrenocorticism
From
Newsletter
From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
